Cytori Therapeutics (CYTX) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Other income (expense), net: -696K
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Other income (expense), net: -696K
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SolarMax Technology (SMXT) Misses Q2 EPS by 98c
- Dominion Energy (D) PT Lowered to $62 at Truist Securities
- UBS Reiterates Neutral Rating on Tractor Supply Company (TSCO) Amid Focus on Top-Line Trends
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
